TY - GEN 
AU - Cuellar-Valencia L
AU - Claros-Hulbert A
AU - Ortegon A
AU - Pino J
AU - Velandia L
AU - Correa-Morales J.E.
PY - 2024
SN - 10499091
UR - http://hdl.handle.net/10818/61902
AB - Background: Levetiracetam has a favorable pharmacology profile to be used subcutaneously. However, its subcutaneous use is still considered off-label as this is beyond its license. The evidence base for its safety, tolerability, and efficacy is...
LA - eng
PB - American Journal of Hospice and Palliative Medicine
KW - home care
KW - levetiracetam
KW - palliative care
KW - seizure
KW - subcutaneous
TI - Subcutaneous Levetiracetam Administration in Latino Patients on Home Care
DO - 10.1177/10499091231212450
ER -